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ABSTRACT
Background: Improving patient flow and reducing over-crowding can improve quality,
promptness of care, and patient satisfaction. Given low utilization of preventive care in low-
resource countries, improved patient flows are especially important in these settings.
Objective: Compare patient flow and provider efficiency between two cervical cancer screen-
ing strategies via self-collected human papillomavirus (HPV).
Methods: We collected time and motion data for patients screened for cervical cancer in 12
communities in rural Migori County, Kenya as part of a larger cluster randomized trial. Six
communities were randomized to screening in community health campaigns (CHCs) and six
to screening at government clinics. We quantified patient flow: duration spent on each active
stage of screening and wait times, and the number of patients arriving at CHCs and clinics
each hour of the day. In addition, for four CHCs, we collected time and motion data for
providers, and measured provider efficiency as a ratio of active (service delivery) time to total
time spent at the clinic.
Results: Total duration of screening visits, at CHCs and clinics was 42 and 87 minutes,
respectively (p < 0.001 for difference). Total active time lasted longer at CHCs, with a mean
of 28 minutes per patient versus 15 minutes at clinics, largely due to differences in duration
for group education (p < 0.001). Wait time for registration at clinics was 36 minutes, explain-
ing most of the difference between settings, but sometimes incorporated other health
services.
Conclusions: There is a substantial difference in patient flow at clinics compared to CHCs.
Shorter duration at CHCs suggests that the model is favorable for patients in limiting time
spent on screening. Future cervical cancer screening programs designed for scale-up should
consider how this advantage may enhance satisfaction and uptake. For clinic-based screening
programs, efforts could be made towards reducing registration wait times.
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Background
Health facilities throughout the world face challenges
providing care to large volumes of patients efficiently.
Improving patient flows and reducing over-crowding
are important issues, as research shows inefficient
patient flows in clinics affect quality and timeliness
of care, safety, and patient satisfaction [1–3]. The
lower access to funding, human capital, and infra-
structure in low-resource countries make optimizing
patient flows essential, but also potentially more chal-
lenging in these settings. Ideally, clinics in low-
resource settings would be able to maximize the effi-
ciency and minimize costs of patient care. However,
health costs in low-resource settings are still poorly
understood, which impedes optimal resource alloca-
tion [4]. Further research that identifies and measures
patient flows and efficiency in low-resource settings
will help health systems seeking to increase access to
care without increasing the availability of resources.
Only a few studies in Sub-Saharan Africa have
measured patient flow in clinical settings. In Ghana,
Best et al (2014) used computer simulation to
improve patient flow in an acute care hospital. They
found that the largest reduction in patient time spent
in the hospital occurred when shift times were coor-
dinated with patient arrival patterns [5]. Wanyenze
et al (2010) measured patient flows at three antire-
troviral therapy (ART) clinics in Uganda in order to
identify the clinic with the shortest wait time for
patients at the clinic [6]. The researchers also con-
cluded that streamlining doctor and counselor activ-
ity could have an effect on patient flow. Another
study in Uganda found that task shifting from doc-
tors to nurses and pharmacy-only visits led to reduc-
tions in total wait time [7]. Scheduled appointment
times with longer appointment times have been
shown to reduce wait times [8].
Patient flow analysis is a quality improvement tool
to help healthcare facilities identify inefficiencies in
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patient flow, and provide suggestions for how to
intervene and improve processes. In recent years,
there have been efforts to systematize and improve
methods of patient flow analysis in resource-limited
settings. Dixon et al (2015) describe the step-wise
approach to patient flow analysis in developing coun-
try settings, and apply their method of patient flow
analysis to a hospital in Ghana. They found that the
average duration of hospital visits was 2 hours longer
than the average duration in emergency departments
in the USA. The stepwise approach termed the 3Ps –
preparation, piloting, and performing – is used as a
flexible guide of items to consider when performing a
patient flow analysis. After performing a patient flow
analysis, the collected data is analyzed as it relates to
the objectives and process measures to help identify
areas for improvement [9].
Cervical cancer screening is one area where patient
efficiency may play a key role in the successful imple-
mentation of health care programs for large numbers
of women at low-costs and with limited staffing.
Cervical cancer is the fourth most common cancer
among women in the world, with over 250,000 deaths
and 500,000 new cases in 2012 [10]. Furthermore,
more than 80% of cervical cancer cases occur in the
least developed countries [11]. Human papilloma-
virus (HPV) causes about 70 percent of all cases of
cervical cancer, and studies in low-resource settings
support the cost-effectiveness of HPV-based cervical
cancer screening [12]. Based on a systematic review
of randomized control trials and observation studies,
the World Health Organization (WHO) issued a new
set of guidelines in 2013 for cervical cancer screen-
and-treat techniques, and recommends the HPV test
followed by treatment with cryotherapy for women
who test positive [13].
A large majority of worldwide cervical cancer bur-
den is in less-developed regions, at about 85%. The
annual number of cervical cancer cases in Sub-
Saharan Africa in 2012 was about 92,000 [14].
Despite new strategies to increase availability of
screening and treatment of cervical pre-cancer,
screening rates remain low in Sub-Saharan African
countries [15]. From a provider survey implemented
in rural Kenya, Rosser et al (2015) found barriers to
screening from the patient perspective including wait
time, discomfort with male providers, and inadequate
knowledge and counseling skills. Providers also cited
shortages of staff and lack of space as barriers to
screening. Long wait times at clinics are common in
Sub-Saharan African countries, where clinics have
limited infrastructure and human resources [16]. A
study at Mulago Hospital in Uganda found that a
very high outpatient load was overwhelming staff
and resources, resulting in long wait times and poor
patient satisfaction. [17] A main driver of the lower
efficiency of healthcare service delivery is
overextended staff, leading to longer wait times for
the consultation, and slower dispensing of drugs and
laboratory tests [18].
Cervical cancer screening programs in low-
resource settings need to reach large numbers of
women, and must include educational programs and
counseling to increase acceptability and reduce
stigma. Despite simplified screening strategies, educa-
tional programs may increase duration of time spent
at clinics when receiving services [19]. Research is
needed on clinical care processes that minimize
total time spent at the clinic for cervical cancer
screening. As low and middle-income countries
establish and expand cervical cancer programs, few
studies have examined the flow of patients, the
sources of bottlenecks and potential avenues for
improving patient flow and quality of care. An under-
standing of patient flow will be essential for sustain-
ing HPV self-sampling scale-up and progressing
toward universal access to cervical cancer screening.
In this study, we conducted a patient flow analysis of
two models of delivering cervical cancer screening via
HPV self-collection using time and motion data. The
purpose was to inform improvement of patient flow
for cervical cancer screening services in low-resource
countries.
Methods
We used time and motion data to estimate the dura-
tion of screening and identify inefficiencies in two
models of cervical cancer screening with self-collected
HPV in a rural county in western Kenya: (1) screen-
ing offered through short-term community health
campaigns (CHCs), where women were screened at
temporary tents set up close to community centers,
and (2) screening integrated into government health
clinics. The goals were to identify bottlenecks in
cervical cancer screening patient flow, and mis-
matches between screening demand and provider
staffing.
Study description
A time and motion study is a method used to char-
acterize the efficiency of service delivery [20]. The
time and motion study involved systematic observa-
tion of all daily tasks carried out in the clinic and
CHCs. We measured the time spent on each of the
daily tasks observed at clinics and CHCs, and used
the data collected to measure standard times required
to perform all aspects of screening. Previous studies
have validated time-and-motion methodologies
within clinical settings to improve procedures, and
increase productivity [21,22].
This time and motion study was conducted as part
of a cluster-randomized clinical trial in 12
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communities in Migori County, in Nyanza, Kenya
between January and September 2016. The target
population was women eligible for cervical cancer
screening per the Kenya Ministry of Health guide-
lines: 25–65 years old with an intact uterus and cer-
vix. Six communities were randomized to offer
screening in CHCs and the remaining six commu-
nities provided screening at government clinics.
Huchko et al (2017) reported the main outcomes of
the trial, which showed that cervical cancer screening
offered in CHCs reached a larger proportion of
women in study communities [23].
In the CHC model, mobile screening activities
were held at up to 10 sites within each community
over a period of two weeks. Sites selected for the
mobile CHC included church compounds, schools,
open fields, and market centers. The CHC tent had a
partitioned area for self-collection, a registration
table, and a group education area. During the day,
community health volunteers (CHVs) conducted
door-to-door mobilization under the supervision of
two program assistants. Samples were processed and
analyzed using the careHPV system which was
located at a laboratory at Migori County Hospital.
The care HPV system provided a positive result if at
least one of the 14 high-risk genotypes of HPV was
identified.
At clinics, the screening workflow was similar to the
CHC except that all steps were performed by a single
CHV. Thewomen could have been visiting the clinic for
other health services or just for cervical cancer screen-
ing. The CHV registered the patients, facilitated indivi-
dual or group education and consent, administered the
pre-test survey, directed patients to self-collection
rooms, and administered the post-test survey. See
Figure 1 for the workflow for CHCs and clinics.
At all 12 communities, women screened for HPV
through self-test kits. Self-testing for HPV, which has
similar sensitivity and specificity to samples taken by
clinicians [24,25], has the potential to address many
barriers to screening and increase the participation
rates of at-risk and hard-to-reach women [26].
Data collection
We collected patient time and motion data to mea-
sure time spent at each stage of cervical cancer
screening at each of the 12 CHCs and clinics.
Provider time and motion data were collected at
four CHCs.
Figure 1. Diagram of patient flow steps at CHCs and clinics for cervical cancer screening.
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Patient time and motion measures collected were
total visit time, time at each stage of the screening
process, wait time between each stage of screening,
and patient arrival patterns. Provider time and
motion included provider productive (service deliv-
ery) and idle time. The method of data collection
differed slightly between CHCs and clinics. At
CHCs, research assistants recorded the amount of
time spent on all activities involved with screening,
from the patient’s arrival to the end of the post-test
questionnaire, using activity forms with time stamps,
programmed on OpenDataKit (ODK) software.
At the beginning of a patient’s visit to the CHC,
research assistants recorded the patient’s arrival time,
and registration start and stop time. The patient then
moved to participate in group education. The start time
for group education depended on the next available
sizeable group of participants. After group education,
the patients would move to a private area where they
would individually sign consent forms with research
assistants. Patients were then issued HPV self-collection
kits and administered a pre-test questionnaire. The
patients entered sample collection rooms and proceeded
with specimen collection. After sample collection was
completed, patients would fill out a post-test question-
naire again administered by the research assistant.
At the clinics, CHVs recorded time spent on paper
forms, which were later entered into the ODK soft-
ware. The main difference for screening at clinics was
the possibility that patients received other services
while they waited for screening services. Education
session wait time was also dependent on the avail-
ability of the CHVs, who were often involved with
other clinic activities. Education sessions could be
done individually or in groups, depending on the
patient volume. At clinics, data quality checks were
put in place to ensure that data recorded by the
research assistants at each of stage of the screening
procedure were consistent across patients.
After both clinic and CHC data were entered into
ODK, we uploaded the data to an ODK Aggregate
server, and imported the data into SAS for manage-
ment (merging, cleaning, sorting) and reporting. We
exported data from SAS to MS Access for further
cleaning and storage in MS Excel format. The costing
team which comprised the costing lead and the cost-
ing assistant transferred the data into clinic and CHC
time and motion Excel workbooks for analysis.
Figure T.S. 1 in the Technical Supplement shows
the time and motion log used by the research assis-
tants and CHVs, either electronically or paper-based.
Analyses
To understand the bottlenecks in cervical cancer
screening in the two clinical models, we descriptively
analyzed the time-and-motion data to measure
differences in patient arrival numbers and patient
and provider time measures. We estimated the num-
ber and timing of patients arriving at CHCs and
clinics to understand the distribution of activity in
an average day. Patient arrival numbers were mea-
sured as the number of patients arriving at the CHC
or clinic during each hour of operation. Patient time
measures included total visit time and total wait time.
Visit time was composed of time at each stage of the
screening process and wait times between each stage.
We also measured and compared averages of pro-
vider times for CHCs, using the provider time-and-
motion data. These included active time (i.e. amount
of time spent on productive clinic/CHC activities)
and idle time (i.e. amount of time spent at the
CHC/clinic waiting).
The final analysis was a comparison of patient and
provider efficiency. Patient efficiency was measured
as the amount of active time (i.e. time spent at the
CHC excluding wait times) divided by the total time
spent at the CHC. Provider efficiency was measured
as the amount of active time (i.e. time spent working
at the CHC excluding idle time) divided by total
working time at the CHC. We hypothesized that
there was a tradeoff between patient efficiency and
provider efficiency, meaning that if there were more
providers at the CHC, then there was a lower like-
lihood that patients needed to wait for each activity
resulting in a high patient efficiency. With more
providers at a CHC, we hypothesized there was a
higher likelihood that providers were idle, which
meant lower provider efficiency.
Results
Between January and September 2016, 2899 women
were screened at the six CHCs, and 2042 women
were screened at clinics. Table 1 compares average
time durations for screening at CHCs and clinics,
broken down by total active and wait times. The
total duration of screening, excluding research time,
at CHCs was 42 minutes and at clinics was 1 hour
and 27 minutes. The difference was statistically sig-
nificant (p < 0.001, t-test = 25.44). Visiting a CHC for
screening saved a patient about 45 minutes. Total
activity time (i.e. time spent on stages related to
screening, excluding wait time) lasted longer at
CHCs, at 28 minutes on average per patient com-
pared to 15 minutes at clinics (p- = 0.00,
t-test = 21.00).
Wait times were extremely long for clinics (36 min-
utes), reflective of the fact that some patients at
clinics may have received other health services before
registering for cervical cancer screening. When
excluding registration, the difference in duration
spent at clinics and CHCs was reduced to 22 minutes
(p < 0.001), suggesting that the difference in wait
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times could be mostly attributed to the longer wait
times for registration.
While group education wait time was considerably
longer for clinic (22 minutes) compared to CHCs
(7 minutes), active time in group education lasted
longer at CHCs. Counseling on cervical cancer
screening at CHCs may have therefore been more
comprehensive, or the group setting may have facili-
tated more questions. Sample collection lasted
slightly, but significantly, longer at CHCs, at 5 min-
utes compared to 4 minutes at clinics (p-value<
0.001). All research activities (group consent, pre-
screening questionnaire, post-test wait time, and
post-screening questionnaire), were aggregated
together for both CHCs and clinics. Research time
lasted longer at CHCs, at 26 minutes compared to
17 minutes at clinics, and this was statistically signif-
icance (p-value<0.001).
Figure 2 shows the number of patients that arrived
to clinics per hour, averaged across community-days.
On average the number of patients that arrived each
hour at clinics was less than one patient. The range in
average number of patients that arrived during an
operating hour was 0.01 to 0.36. The highest amount
of activity at clinics was in the morning, between 9am
and 12pm; the patient arrival rate declined gradually
after 12pm.
The distribution of patients arriving at CHCs was
different in size and shape relative to clinics. In
Figure 3, we can see that the busiest hours for
CHCs were from 1 to 4pm. CHCs were also clearly
busier than clinics, where the average number of
patients that arrived in a given hour ranged from
less than one to slightly less than eight patients
between 3 to 4pm. We overlaid the number of pro-
viders staffed at CHCs each hour, on average. The
number of providers engaged in patient care
remained high from 8am to 4pm, with a few engaged
at the CHCs between 4 and 6pm. While numbers of
providers staffed suggests that there may have been
an oversupply of providers in the mornings at CHCs,
the ratio of providers to patients is fairly stable,
remaining between 1 and 3 per patient arriving in
an hour (besides at 9am and 5pm which are the
starting and close times).
Comparison of patient efficiency and provider
efficiency
Table 2 shows the average provider time spent active,
idle, and on research in a day at a CHC. Provider
active time is on average 2 hours, idle time is 4 hours
and 16 minutes, and research time is an hour and
26 minutes. The total provider time spent at a CHC
on average is slightly less than 8 hours.
In Figure 4, we compare provider efficiency and
patient efficiency at CHCs in a scatterplot. We use
the provider measures in Table 2 to estimate provider
efficiency. Each observation in the scatterplot repre-
sents the estimated provider efficiency in a day rela-
tive to the estimated patient efficiency in a day. There
are a total of 40 observations in the scatterplot from
the four CHCs with time-and-motion data. The line
of best fit through the scatterplot shows that there
was a clear negative relationship between provider
efficiency and patient efficiency, which confirms our
hypothesis that with improved patient efficiency,
there is a higher likelihood that providers end up
being idle.
Discussion
The results of this study provide some insights into
the processes and efficiencies of implementing cervi-
cal cancer screening in low-resource, rural areas. The
first finding is that cervical cancer screening at CHCs
provided a quicker and more efficient experience for
women than screening at clinics, and the time savings
was largely due to differences in wait times. A study
conducted in Uganda also demonstrated that CHCs
Table 1. Average duration for total visit, wait time, and
stages of screening, per patient, for CHCs and clinics.
HH:MM per patient CHCs Clinics p-value
Total duration of screening 0:42 1:27 <0.001
(0:23) (1:19)
Total activity time 0:28 0:15 <0.001
(0:18) (0:10)
Total wait time 0:15 1:12 <0.001
(0:13) (1:17)
Total wait time excl. registration 0:14 0:36 <0.001
(0:11) (0:56)
Registration wait time 0:01 0:36 <0.001
(0:05) (0:53)
Registration 0:03 0:02 0.20
(0:15) (0:06)
Group education wait time 0:07 0:22 <0.001
(0:06) (0:49)
Group education 0:19 0:09 <0.001
(0:08) (0:07)
Sample collection 0:05 0:04 <0.001
(0:03) 0:02
Time spent on research 0:26 0:17 <0.001
(includes wait time) (0:12) (0:11)
Total duration of screening excludes any activity or wait time related to
research. Standard errors in parentheses.
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Figure 2. Number of patients arriving to clinics per hour,
averaged across community-days.
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provided a rapid approach to testing a majority of
residents for HIV in rural African settings [27]. The
CHCs in our study achieved the target adopted by the
Kenya Ministry of Health patient charter with overall
wait times at 15 minutes, compared to the 20 minutes
charter target [28]. Time savings have been identified
as an important opportunity cost that should be
measured, valued, and included in cost-effectiveness
analyses of cervical cancer screening [29].
Our results also show that clinics, had longer
registration wait times than CHCs. A study on
patients in Malaysia also showed that patients experi-
enced long wait times to register to see a doctor [30].
The main reason for late registration was due to
inadequate staff. In our study, long wait times at
clinics was driven by patients’ need to re-register
and wait for other services like maternal and child
health services. Clinics could improve efficiency by
0
1
2
3
4
5
6
7
8
9
10
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Clients Arriving Providers Staffed Provider/Patient Ratio
Figure 3. Number of patients arriving, providers staffed, and provider-patient ratio by hour, at CHCs, averaged across
community-days.
Table 2. Provider time spent on activity, idle,
and research, averaged per provider per day.
HH:MM per provider per day CHCs
Active Time 2:03
(2:10)
Idle Time 4:16
(2:07)
Research Time 1:26
(1:44)
Total Duration 7:45
(1:43)
CHCs lasted for 10 working days. Total number of obser-
vations at the provider-day level was 347. Total number
of providers across the four CHCs was 18.
Figure 4. Scatter plot of provider efficiency (i.e. ratio of active time to total work time) and patient efficiency (i.e. ratio of active
time to total time spent at CHC) for each community-day, across 4 CHCs, with line of best fit.
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reducing registration wait time through integration of
cervical cancer screening as part of a larger package
of maternal services; for example, integrating with
HIV testing and care. One study in Zambia found
that increasing linkages and improving integration of
HIV and sexual and reproductive health services led
to more cost-effective service delivery [31].
The total difference in wait time between CHCs
and clinics, excluding the registration wait time, was
still large (22 minutes) and significant. Community
health volunteers may have worked at maximum
capacity to service a larger than expected number of
patients, possibly resulting in the long wait times
post-registration. Another possible solution is for
clinics to ensure that a greater number of trained
staff are available during peak hours, and schedule
for staff downtime during periods of low demand. A
similar recommendation has been previously made to
counter this challenge in outpatient settings [32].
Another finding from the study was that total
activity times (time spent on screening-related tasks)
were shorter at clinics, and this difference was most
pronounced in the differences in time spent on group
education: CHCs spent on average 19 minutes on
group education, and clinics spent on average 9 min-
utes. From the study protocol, the group education
module takes approximately 15 minutes to administer
[33]. At clinics, since CHVs were required facilitate
the entire screening process, the CHV likely focused
on patient volumes and the need to attend to all
within the available time. The CHV therefore may
have shortened time spent on group education. The
other possible explanation is that since there were
lower volumes of women screening at any given
time at the clinics, group education lessons moved
more quickly. If CHVs, indeed, had less time to
spend with their patients because of issues of capa-
city, then women had less time to ask the provider
questions and better understand the process of
screening and testing. Addressing provider capacity
at clinics therefore could increase the necessary time
spent to provide care to patients, help patients under-
stand the screening process and subsequent testing
procedures, and reduce the amount of wait time
spent at clinics.
Another finding was the relationship between pro-
vider staffing and number of patients arriving for
cervical cancer screening services. From our analyses
of patient arrivals and provider staffing at CHCs, we
found that the number of providers relative to
patients arriving at the clinic were slightly higher in
the mornings than in the afternoons, although provi-
der-patient ratios did not exceed 3 between 10am and
4pm. We also found that there was a tradeoff in
provider efficiency (i.e. ratio of active time to total
time working) and patient efficiency at CHCs (i.e.
ratio of active time to total time spent at the clinic).
For future CHCs that will be implemented for cervi-
cal cancer screening in low-income, rural settings,
there are benefits for patients to have higher provi-
der-patient ratios because more providers staffed
means lower likelihood of long wait times at the
CHC. With the goal of achieving more efficient allo-
cation of resources for cervical cancer screening pro-
grams, future implementers could also consider more
efficiently staffing providers based on projected num-
bers of patients who arrive at the clinic or CHC for
screening.
Finally, both cervical cancer screening models
implemented self-testing for HPV, which is an attrac-
tive option for other cervical cancer programs
because of the convenience and time-efficiency.
Women in other contexts have reported that self-
testing helped overcome long wait times at the clinic
and thus reduced the amount of time spent away
from work [34]. More recently, self-testing for HPV
has become more common in low and middle-
income countries, and governments are in the process
of considering expanded programs and different
delivery models for HPV-screening. In doing so, con-
siderations of the optimal implementation model
should include patient visit time and the implications
of staffing levels on provider and patient efficiency.
Limitations of the study
Our study has several limitations. The first was that
women at clinics who were waiting to register for
screening often received other services besides cervical
cancer screening during their time waiting. We do not
have data on whether women attended clinic solely for
cervical cancer screening. Because women self-
reported their arrival times, the study team may have
included the time spent on other services as registra-
tion wait time, which extended the recorded wait times
for registration. Therefore, wait times recorded may
not be an accurate measure of pre-screening wait,
although total duration at the clinic is accurate.
Future studies should document and incorporate eva-
luation of whether women received other services
while at the clinic when waiting for screening services.
Another limitation is that provider time and motion
data was collected in four CHCs only. We did not
collect time-and-motion data in the first two commu-
nities to ensure that we were collecting data from
CHCs with resolved implementation issues. However,
this prevented a larger sample to measure the relation-
ship between provider efficiency and patient efficiency,
and also prevented comparison with clinics. The final
limitation is that while we did find shorter time dura-
tions spent on cervical cancer screening at CHCs, each
CHC required a larger team to implement screening
activities, and the availability of screening in commu-
nities only lasted for two weeks. Implementers and
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policymakers considering the expansion of cervical
cancer screening in low-resource countries need to
consider these tradeoffs when making decisions on
screening models.
Conclusion
This is the first study to compare patient flows for
different cervical cancer screening models in a rural
area of a low-resource country, to our knowledge,
and one of few patient flow studies in these settings.
Our results inform health systems and program
implementers on how to successfully sustain and
scale programs in HPV self-sampling, and influence
further progress toward universal access of cervical
cancer prevention.
Recommendations
Future studies could explore the effects of reducing
clinic durations by consolidating registration across
other health care services or adjusting provider staff-
ing at CHCs based on projected number of patients
arriving at the CHC. Importantly, future studies
should explore the patient perspective and experience
with various visit lengths and wait times.
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